Abstract
Randomized, double-blind, placebo-controlled trials have provided compelling evidence that treatment with prednisolone improves outcome in patients with acute idiopathic peripheral facial (Bell's) palsy. The low rate of adverse effects, the small number needed to treat, and the modest cost of therapy indicate that prednisolone should be used in all patients with facial palsy of <72 h duration who do not have contraindications to steroid therapy. By contrast, the best-designed recent clinical trials have failed to suggest any significant beneficial effect on Bell's palsy of treatment with acyclovir or valacyclovir, either as single agents or in combination with prednisolone. Antiviral therapy should not, therefore, be routinely used in the treatment of Bell's palsy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effects of electroacupuncture therapy for Bell’s palsy from acute stage: study protocol for a randomized controlled trial
Trials Open Access 25 August 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
McCormick DP (2000) Herpes simplex as a cause of Bell's palsy. Rev Med Virol 10: 285–289
Kawaguchi K et al. (2007) Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope 117: 147–156
Murakami S et al. (1996) Bell's palsy and herpes simplex virus: identification of viral DNA in endoneural fluid and muscle. Ann Intern Med 124: 27–30
Furuta Y et al. (1998) Reactivation of herpes simplex virus type 1 in patients with Bell's palsy. J Med Virol 54: 162–166
Abiko Y et al. (2002) Secretion and dynamics of herpes simplex virus in tears and saliva of patients with Bell's palsy. Otol Neurotol 23: 779–783
Adour KK et al. (1996) Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 105: 371–378
Allen D and Dunn L. Aciclovir or valacyclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Systematic Reviews 2004, Issue 3. Art. No.: CD001869. 10.1002/14651858.CD001869.pub2
Sullivan AD et al. (2007) Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 357: 1598–1607
Hato H et al. (2007) Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 28: 408–413
Engstom M et al. (2008) Prednisolone and valacyclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicenter trial. Lancet Neurol 7: 993–1000
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Tyler, K. Prednisolone—but not antiviral drugs—improves outcome in patients with Bell's palsy. Nat Rev Neurol 5, 74–75 (2009). https://doi.org/10.1038/ncpneuro1002
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro1002
This article is cited by
-
Effects of electroacupuncture therapy for Bell’s palsy from acute stage: study protocol for a randomized controlled trial
Trials (2015)
-
Erkrankungen des N. facialis
HNO (2010)
-
Neuro-ophthalmologic Complications and Manifestations of Upper and Lower Motor Neuron Facial Paresis
Current Neurology and Neuroscience Reports (2010)
